We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

Find a share

Search for UK shares

Search

Market movers

United Kingdom
movers are constituents of the FTSE 350.
% GainersCompany
content
IC ViewLastChange
Betfair Group PLC
BET:LSE
2,105
GBX
+319.00
+17.86%
Spirax-Sarco Engineering PLC
SPX:LSE
3,407
GBX
+327.00
+10.62%
Aviva PLC
AV.:LSE
569.50
GBX
+37.50
+7.05%
Pace PLC
PIC:LSE
382.50
GBX
+22.90
+6.37%
Essentra PLC
ESNT:LSE
1,039
GBX
+53.00
+5.38%
Serco Group PLC
SRP:LSE
217.80
GBX
+11.00
+5.32%
Moneysupermarket.Com Group PLC
MONY:LSE
272.00
GBX
+13.00
+5.02%
Morgan Advanced Materials PLC
MGAM:LSE
339.00
GBX
+15.90
+4.92%
Schroders PLC
SDR:LSE
3,178
GBX
+144.00
+4.75%
Standard Life PLC
SL.:LSE
442.00
GBX
+18.80
+4.44%
As of Mar 05 2015 17:07 GMT.

Companies news

Who bought who
Deal status
Deal value
Date
AbbVie IncacquiredPharmacyclics IncAnnounced20.77bn04 Mar 2015
NXP Semiconductors NVacquiredFreescale Semiconductor LtdAnnounced11.22bn02 Mar 2015
Hewlett Packard CoacquiredAruba Networks IncAnnounced2.81bn02 Mar 2015
PacWest Bancorp,Los Angeles CaliforniaacquiredSquare 1 Financial IncAnnounced814.53m02 Mar 2015
Mitel Networks CorpacquiredMavenir Systems IncAnnounced556.84m02 Mar 2015
1-5 of 11 results

Companies news

Financial Times articles may require a separate login and/or subscription to FT.com

Ecopetrol taps ex-finance minister for top job
Britishness may not be enough for Fraser’s
Noble Group pledges greater transparency
Fed tests point to $500bn risk for banks
AbbVie deal adds to pharma scramble

Featured company

No Companies Currently Featured
© Thomson Reuters Click for restrictions.

All markets data located on Investors Chronicle is subject to the Investors Chronicle Terms & Conditions.

All content on Investors Chronicle is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Investors Chronicle and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Conditions.

Advertiser reports

Register today and get...

Register today and get...
Please note terms & conditions apply